Type 2 diabetes mellitus, dyslipidemia, and Alzheimer’s disease

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin

(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · see citing works

Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance

Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1× · see citing works

Neurovascular regulation in the normal brain and in Alzheimer's disease

Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213 · see citing works

Risk of dementia in diabetes mellitus: a systematic review

Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187 · see citing works

Diabetes mellitus and the risk of dementia: The Rotterdam Study

Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175 · see citing works

Mitochondrial dysfunction and type 2 diabetes

Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070 · see citing works

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

(2006) · The Lancet · doi:10.1016/s0140-6736(06)69420-8 · Cited by 1,706 · see citing works

Viability thresholds and the penumbra of focal ischemia

Hossmann, K. (1994) · Annals of Neurology · doi:10.1002/ana.410360404 · Cited by 1,370 · see citing works

Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E., Frosch, M., Eckman, C., Tanzi, R., Selkoe, D., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0230450100 · Cited by 1,361 · see citing works

Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease

Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kåreholt, I., Winblad, B., Helkala, E.-L., Tuomilehto, J., Soininen, H., & Nissinen, A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1556 · Cited by 1,291 · see citing works

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.661 · Cited by 1,258 · see citing works

Midlife cardiovascular risk factors and risk of dementia in late life

Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C., & Yaffe, K. (2005) · Neurology · doi:10.1212/01.wnl.0000149519.47454.f2 · Cited by 1,238 · see citing works

Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies

Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207 · see citing works

Alzheimer’s disease is type 3 diabetes—Evidence reviewed

de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158 · see citing works

The metabolic syndrome, inflammation, and risk of cognitive decline

Yaffe, K. (2004) · JAMA · doi:10.1001/jama.292.18.2237 · Cited by 1,025 · see citing works

Midlife blood pressure and dementia: the Honolulu–Asia aging study☆

Launer, L. J., Ross, G. W., Petrovitch, H., Masaki, K., Foley, D., White, L. R., & Havlik, R. J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00096-8 · Cited by 1,008 · see citing works

Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model

Refolo, L. M., Pappolla, M. A., Malester, B., LaFrancois, J. J., Bryant‐Thomas, T., Wang, R., Tint, G. S., Sambamurti, K., & Duff, K. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0304 · Cited by 1,003 · see citing works

Alzheimer Disease as a Vascular Disorder

de la Torre, J. C. (2002) · Stroke · doi:10.1161/01.str.0000014421.15948.67 · Cited by 844 · see citing works

Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics

de la Torre, J. C. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00683-0 · Cited by 834 · see citing works

Intranasal insulin improves cognition and modulates β-amyloid in early AD

Reger, M. A., Watson, G. S., Green, P. S., Wilkinson, C. W., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Breitner, J. C. S., DeGroodt, W., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000265401.62434.36 · Cited by 830 · see citing works

Insulin and neurodegenerative disease: shared and specific mechanisms

Craft, S., & Stennis Watson, G. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00681-7 · Cited by 830 · see citing works

Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study

Yoshitake, T., Kiyohara, Y., Kato, I., Ohmura, T., Iwamoto, H., Nakayama, K., Ohmori, S., Nomiyama, K., Kawano, H., Ueda, K., et al. (1995) · Neurology · doi:10.1212/wnl.45.6.1161 · Cited by 829 · see citing works

Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation

Qiu, W. Q., Walsh, D. M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M. B., Rosner, M. R., Safavi, A., Hersh, L. B., & Selkoe, D. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32730 · Cited by 812 · see citing works

An 18-Year Follow-up of Overweight and Risk of Alzheimer Disease

Gustafson, D., Rothenberg, E., Blennow, K., Steen, B., & Skoog, I. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.13.1524 · Cited by 811 · see citing works

Aggregation of vascular risk factors and risk of incident Alzheimer disease

Luchsinger, J. A., Reitz, C., Honig, L. S., Tang, M. X., Shea, S., & Mayeux, R. (2005) · Neurology · doi:10.1212/01.wnl.0000172914.08967.dc · Cited by 790 · see citing works

β-Amyloid-mediated vasoactivity and vascular endothelial damage

Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) · Nature · doi:10.1038/380168a0 · Cited by 703 · see citing works

Risk of Dementia among Persons with Diabetes Mellitus: A Population-based Cohort Study

Leibson, C. L., Rocca, W. A., Hanson, V. A., Cha, R., Kokmen, E., O'Brien, P. C., & Palumbo, P. J. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009106 · Cited by 700 · see citing works

Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer’s disease

Risner, M. E., Saunders, A. M., Altman, J. F. B., Ormandy, G. C., Craft, S., Foley, I. M., Zvartau-Hind, M. E., Hosford, D. A., Roses, A. D., & for the Rosiglitazone in Alzheimer's Disease Study Group (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500369 · Cited by 686 · see citing works

Hyperinsulinemia and risk of Alzheimer disease

Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140292.04932.87 · Cited by 683 · see citing works

Diabetes Mellitus and Risk of Alzheimer's Disease and Dementia with Stroke in a Multiethnic Cohort

Luchsinger, J. A. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.7.635 · Cited by 682 · see citing works

Apolipoprotein E ε4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease

Kivipelto, M., Helkala, E., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Iivonen, S., Mannermaa, A., Tuomilehto, J., Nissinen, A. M., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-3-200208060-00006 · Cited by 645 · see citing works

Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone

Watson, G. S., Cholerton, B. A., Reger, M. A., Baker, L. D., Plymate, S. R., Asthana, S., Fishel, M. A., Kulstad, J. J., Green, P. S., Cook, D. G., et al. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.11.950 · Cited by 607 · see citing works

Pattern of Cerebral Hypoperfusion in Alzheimer Disease and Mild Cognitive Impairment Measured with Arterial Spin-labeling MR Imaging: Initial Experience

Johnson, N. A., Jahng, G., Weiner, M. W., Miller, B. L., Chui, H. C., Jagust, W. J., Gorno‐Tempini, M. L., & Schuff, N. W. (2005) · Radiology · doi:10.1148/radiol.2343040197 · Cited by 580 · see citing works

Induction of Alzheimer-like β-Amyloid Immunoreactivity in the Brains of Rabbits with Dietary Cholesterol

Sparks, D. L., Scheff, S. W., Hunsaker, J. C., Liu, H., Landers, T. M., & Gross, D. R. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1044 · Cited by 559 · see citing works

The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function

Awad, N., Gagnon, M., & Messier, C. (2004) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490514875 · Cited by 551 · see citing works

Is Type II Diabetes Associated With an Increased Risk of Cognitive Dysfunction?: A critical review of published studies

Strachan, M. W. J., Deary, I. J., Ewing, F. M. E., & Frier, B. M. (1997) · Diabetes Care · doi:10.2337/diacare.20.3.438 · Cited by 529 · cited 1× · see citing works

Mitochondrial dysfunction: An early event in Alzheimer pathology accumulates with age in AD transgenic mice

Hauptmann, S., Scherping, I., Dröse, S., Brandt, U., Schulz, K. L., Jendrach, M., Leuner, K., Eckert, A., & Müller, W. E. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.005 · Cited by 469 · see citing works

Alzheimer's disease

Mucke, L. (2009) · Nature · doi:10.1038/461895a · Cited by 456 · see citing works

Advanced Glycation End Products in Alzheimer's Disease and Other Neurodegenerative Diseases

Sasaki, N., Fukatsu, R., Tsuzuki, K., Hayashi, Y., Yoshida, T., Fujii, N., Koike, T., WAKAYAMA, I., Yanagihara, R. T., Garruto, R. M., et al. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65659-3 · Cited by 411 · see citing works

Diabetes mellitus and risk of dementia in the Kungsholmen project

Xu, W., Qiu, C., Wåhlin, Å., Winblad, B. G., & Fratiglioni, L. (2004) · Neurology · doi:10.1212/01.wnl.0000140291.86406.d1 · Cited by 409 · see citing works

SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein

Iadecola, C., Zhang, F., Niwa, K., Eckman, C., Turner, S. K., Fischer, E., Younkin, S., Borchelt, D. R., Hsiao, K. K., & Carlson, G. A. (1999) · Nature Neuroscience · doi:10.1038/5715 · Cited by 399 · see citing works

Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease

Sato, T., Hanyu, H., Hirao, K., Kanetaka, H., Sakurai, H., & Iwamoto, T. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.10.009 · Cited by 387 · see citing works

Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease

Jarvik, G. P., Wijsman, E. M., Kukull, W. A., Schellenberg, G. D., Yu, C., & Larson, E. B. (1995) · Neurology · doi:10.1212/wnl.45.6.1092 · Cited by 371 · see citing works

Molecular Insights and Therapeutic Targets for Diabetic Endothelial Dysfunction

Xu, J., & Zou, M. (2009) · Circulation · doi:10.1161/circulationaha.108.835223 · Cited by 348 · see citing works

Metabolic Syndrome and Risk for Incident Alzheimer's Disease or Vascular Dementia

Raffaitin, C., Gin, H., Empana, J. P., Helmer, C., Berr, C., Tzourio, C., Portet, F., Dartigues, J., Alpérovitch, A., & Barberger‐Gateau, P. (2008) · Diabetes Care · doi:10.2337/dc08-0272 · Cited by 338 · see citing works

Contribution of Vascular Risk Factors to the Progression in Alzheimer Disease

Helzner, E., Luchsinger, J. A., Scarmeas, N., Cosentino, S., Brickman, A. M., Glymour, M. M., & Stern, Y. (2009) · Archives of Neurology · doi:10.1001/archneur.66.3.343 · Cited by 329 · see citing works

Signaling by insulin-like growth factor 1 in brain

Bondy, C. A., & Cheng, C. M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.042 · Cited by 323 · see citing works

The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations

Allen, K. V., Frier, B. M., & Strachan, M. W. J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.054 · Cited by 319 · see citing works

Diabetes mellitus and the Risk of Dementia, Alzheimer’s Disease and Vascular Cognitive Impairment in the Canadian Study of Health and Aging

MacKnight, C., Rockwood, K., Awalt, E., & McDowell, I. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000064928 · Cited by 313 · see citing works

Modulation of memory by insulin and glucose: Neuropsychological observations in Alzheimer’s disease

Watson, G. S., & Craft, S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.048 · Cited by 307 · see citing works

Vascular Risk Factors for Incident Alzheimer Disease and Vascular Dementia: The Cache County Study

Hayden, K. M., Zandi, P. P., Lyketsos, C. G., Khachaturian, A. S., Bastian, L. A., Charoonruk, G., Tschanz, J. T., Norton, M. C., Pieper, C. F., Munger, R. G., et al. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213814.43047.86 · Cited by 293 · see citing works

Mid- and Late-Life Diabetes in Relation to the Risk of Dementia

Xu, W., Qiu, C., Gatz, M., Pedersen, N. L., Johansson, B., & Fratiglioni, L. (2009) · Diabetes · doi:10.2337/db08-0586 · Cited by 284 · see citing works

Diabetes Mellitus and Risk of Developing Alzheimer Disease

Akomolafe, A., Beiser, A., Meigs, J. B., Au, R., Green, R. C., Farrer, L. A., Wolf, P. A., & Seshadri, S. S. (2006) · Archives of Neurology · doi:10.1001/archneur.63.11.1551 · Cited by 281 · see citing works

Uncontrolled diabetes increases the risk of Alzheimer’s disease: a population-based cohort study

Xu, W. L., von Strauss, E., Qiu, C. X., Winblad, B., & Fratiglioni, L. (2009) · Diabetologia · doi:10.1007/s00125-009-1323-x · Cited by 272 · see citing works

Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada

Tyas, S. L., Manfreda, J., Strain, L. A., & Montgomery, P. R. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.3.590 · Cited by 272 · see citing works

Insulin increases CSF Aβ42 levels in normal older adults

Watson, G. S., Peskind, E. R., Asthana, S., Purganan, K., Wait, C., Chapman, D., Schwartz, M. W., Plymate, S. R., & Craft, S. (2003) · Neurology · doi:10.1212/01.wnl.0000065916.25128.25 · Cited by 265 · see citing works

Local protein synthesis and its role in synapse-specific plasticity

Martin, K. C., Barad, M., & Kandel, E. R. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00128-8 · Cited by 258 · see citing works

Association Between Dementia and Midlife Risk Factors: the Radiation Effects Research Foundation Adult Health Study

Yamada, M., Kasagi, F., Sasaki, H., Masunari, N., Mimori, Y., & Suzuki, G. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51117.x · Cited by 255 · see citing works

Impaired insulin secretion increases the risk of Alzheimer disease

Rönnemaa, E., Zethelius, B., Sundelöf, J. E., Sundström, J., Degerman-Gunnarsson, M., Berne, C., Lannfelt, L., & Kilander, L. (2008) · Neurology · doi:10.1212/01.wnl.0000310646.32212.3a · Cited by 240 · see citing works

Angiotensin-Converting Enzyme Inhibitors and Cognitive Decline in Older Adults With Hypertension

Sink, K. M., Leng, X., Williamson, J. D., Kritchevsky, S. B., Yaffe, K. S., Kuller, L. H., Yaşar, S., Atkinson, H. H., Robbins, M. E. C., Psaty, B. M., et al. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.175 · Cited by 237 · see citing works

Longitudinal association of vascular and Alzheimer’s dementias, diabetes, and glucose tolerance

Curb, J. D., Rodríguez, B. L., Abbott, R. D., Petrovitch, H., Ross, G. W., Masaki, K., Foley, D. J., Blanchette, P. L., Harris, T. B., Chen, R., et al. (1999) · Neurology · doi:10.1212/wnl.52.5.971 · Cited by 231 · see citing works

Risk of Incident Alzheimer's Disease in Diabetic Patients: A Systematic Review of Prospective Trials

Kopf, D., & Frölich, L. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1011 · Cited by 225 · see citing works

A Neuropsychological Test Battery for Use in Alzheimer Disease Clinical Trials

Harrison, J., Minassian, S. L., Jenkins, L., Black, R. S., Koller, M., & Grundman, M. (2007) · Archives of Neurology · doi:10.1001/archneur.64.9.1323 · Cited by 225 · see citing works

Different Patterns of Cerebral Injury in Dementia With or Without Diabetes

Sonnen, J. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.579 · Cited by 223 · see citing works

The Metabolic Syndrome and Development of Cognitive Impairment Among Older Women

Yaffe, K., Weston, A. L., Blackwell, T., & Krueger, K. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.566 · Cited by 220 · see citing works

The Effect of Borderline Diabetes on the Risk of Dementia and Alzheimer’s Disease

Xu, W., Qiu, C., Winblad, B. G., & Fratiglioni, L. (2006) · Diabetes · doi:10.2337/db06-0879 · Cited by 218 · see citing works

Adiposity, Type 2 Diabetes, and Alzheimer's Disease

Luchsinger, J. A., & Gustafson, D. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1022 · Cited by 212 · see citing works

Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus

Valente, T., Gella, A., Fernàndez‐Busquets, X., Unzeta, M., & Durany, N. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.09.008 · Cited by 210 · see citing works

Serum cholesterol, APOE genotype, and the risk of Alzheimer’s disease: A population-based study of African Americans

Evans, R. M., Emsley, C. L., Gao, S., Sahota, A. S., Hall, K. S., Farlow, M. R., & Hendrie, H. C. (2000) · Neurology · doi:10.1212/wnl.54.1.240 · Cited by 209 · see citing works

Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies

Gerozissis, K. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.050 · Cited by 197 · see citing works

Brain glucose transporters, O‐GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer’s disease

Liu, Y. M., Liu, F., Grundke, I., Iqbal, K., & Gong, C. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06320.x · Cited by 193 · see citing works

Exogenous Aβ1–40 Reproduces Cerebrovascular Alterations Resulting from Amyloid Precursor Protein Overexpression in Mice

Niwa, K., Carlson, G. A., & Iadecola, C. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200012000-00005 · Cited by 191 · see citing works

Systemic Inflammation, Infection, ApoE Alleles, and Alzheimer Disease: A Position Paper

Finch, C. E., & Morgan, T. E. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362254 · Cited by 180 · see citing works

Metabolic syndrome and dementia risk in a multiethnic elderly cohort

Muller, M., Tang, M.-X., Schupf, N., Manly, J. J., Mayeux, R., & Luchsinger, J. A. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000105927 · Cited by 175 · see citing works

Coronary Heart Disease in Patients With Diabetes

Berry, C., Tardif, J., & Bourassa, M. G. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.046 · Cited by 170 · see citing works

Cerebral Blood Flow Velocity and Periventricular White Matter Hyperintensities in Type 2 Diabetes

Novak, V., Last, D., Alsop, D. C., Abduljalil, A., Hu, K., Lepicovsky, L., Cavallerano, J. D., & Lipsitz, L. A. (2006) · Diabetes Care · doi:10.2337/dc06-0261 · Cited by 165 · see citing works

Vascular Risks and Incident Dementia: Results from a Cohort Study of the Very Old

Brayne, C., Gill, C., Huppert, F. A., Barkley, C., Gehlhaar, E., Girling, D. M., O’Connor, D., & Paykel, E. S. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017043 · Cited by 159 · see citing works

Fasting insulin and incident dementia in an elderly population of Japanese-American men

Peila, R., Rodriguez, B. L., White, L. R., & Launer, L. J. (2004) · Neurology · doi:10.1212/01.wnl.0000129989.28404.9b · Cited by 152 · see citing works

Serum total cholesterol, statins and cognition in non-demented elderly

Solomon, A., Kåreholt, I., Ngandu, T., Wolozin, B., MacDonald, S. W. S., Winblad, B., Nissinen, A., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.09.012 · Cited by 149 · see citing works

Risk of developing dementia in people with diabetes and mild cognitive impairment

Velayudhan, L., Poppe, M., Archer, N. J., Proitsi, P., Brown, R. G., & Lovestone, S. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.109.067942 · Cited by 141 · see citing works

Estimated County-Level Prevalence of Diabetes and Obesity - United States, 2007

(2009) · PsycEXTRA Dataset · doi:10.1037/e552192010-002 · Cited by 134 · see citing works

Endothelial function in human coronary arteries in vivo. Focus on hypercholesterolemia.

Drexler, H., & Zeiher, A. M. (1991) · Hypertension · doi:10.1161/01.hyp.18.4_suppl.ii90 · Cited by 131 · see citing works

Cholesterol, <i>APOE</i> genotype, and Alzheimer disease: An epidemiologic study of Nigerian Yoruba

Hall, K., Murrell, J., Ogunniyi, A., Deeg, M., Baiyewu, O., Gao, S., Gureje, O., Dickens, J., Evans, R., Smith-Gamble, V., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000194507.39504.17 · Cited by 128 · see citing works

Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer’s disease mouse models with abundant Aβ in plasma

Burgess, B. L., McIsaac, S. A., Naus, K. E., Chan, J. Y., Tansley, G., Yang, J., Miao, F., Ross, C. J., Eck, M. V., & Hayden, M. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.007 · Cited by 126 · see citing works

The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): Rationale, Design, and Methods

Williamson, J. D., Miller, M. E., Bryan, R. N., Lazar, R. M., Coker, L. H., Johnson, J., Cukierman, T., Horowitz, K. R., Murray, A. M., & Launer, L. J. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.029 · Cited by 124 · see citing works

Thickened cerebral cortical capillary basement membranes in diabetics.

Pc, J., Brendel, K., & Meezan, E. (1982) · PubMed · Cited by 115 · see citing works

Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.

Yamagishi, S., Takeuchi, M., Inagaki, Y., Nakamura, K., & Imaizumi, T. (2003) · PubMed · Cited by 114 · see citing works

Effects of Simvastatin on Cerebrospinal Fluid Biomarkers and Cognition in Middle-Aged Adults at Risk for Alzheimer's Disease

Carlsson, C. M., Gleason, C. E., Hess, T., Moreland, K. A., Blazel, H. M., Koscik, R. L., Schreiber, N. T. N., Johnson, S. C., Atwood, C., Puglielli, L., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13209 · Cited by 92 · see citing works

Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease

Sanz, C., Andrieu, S., Sinclair, A. J., Hanaire, H. P., & Vellas, B. J. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bd80e9 · Cited by 90 · see citing works

Physiological levels ofβ-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production

Price, J. M., Chi, X., Hellermann, G., & Sutton, E. T. (2001) · Neurological Research · doi:10.1179/016164101101198758 · Cited by 80 · see citing works

Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia

Watanabe, T., Koba, S., Kawamura, M., Itokawa, M., Idei, T., Nakagawa, Y., Iguchi, T., & Katagiri, T. (2004) · Metabolism · doi:10.1016/j.metabol.2003.11.020 · Cited by 77 · see citing works

ADCS Prevention Instrument Project: Overview and Initial Results

Ferris, S. H., Aisen, P. S. S., Cummings, J. L., Galasko, D. R., Salmon, D. P., Schneider, L. S. S., Sano, M. C., Whitehouse, P. J., Edland, S. D., & Thal, A. L. J. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213870.40300.21 · Cited by 75 · see citing works

Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease

Watson, G. S., Bernhardt, T., Reger, M. A., Cholerton, B., Baker, L. D., Peskind, E. R., Asthana, S., Plymate, S. R., Frölich, L., & Craft, S. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.11.011 · Cited by 75 · see citing works

Type II diabetes in mild cognitive impairment and Alzheimer’s disease: Results from a prospective population-based study in Germany

Toro, P., Schönknecht, P., & Schröder, J. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0981 · Cited by 71 · see citing works

Association of arterial stiffness with HbA1c in 1,000 type 2 diabetic patients with or without hypertension

Chen, Y., Huang, Y., Li, X., Xu, M., Bi, Y., Zhang, Y., Gu, W., & Ning, G. (2009) · Endocrine · doi:10.1007/s12020-009-9221-z · Cited by 67 · see citing works

Increased amyloid β-peptide (1–40) level in brain of streptozotocin-induced diabetic rats

Liu, Y., Liu, H., Yang, J., Liu, X., Lü, S., Wen, T., Xie, L. Y., & Wang, G. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.03.019 · Cited by 59 · see citing works

Identification of the Alzheimer's disease amyloid precursor protein (APP) and its homologue APLP2 as essential modulators of glucose and insulin homeostasis and growth

Needham, B. E., Wlodek, M. E., Ciccotosto, G. D., Fam, B. C., Masters, C. L., Proietto, J., Andrikopoulos, S., & Cappai, R. (2008) · The Journal of Pathology · doi:10.1002/path.2343 · Cited by 55 · see citing works

Vascular Factors in Diabetes and Alzheimer's Disease

Taguchi, A. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0975 · Cited by 47 · see citing works

Common Pathological Processes and Transcriptional Pathways in Alzheimer's Disease and Type 2 Diabetes

Jones, A., Kulozik, P., Ostertag, A., & Herzig, S. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0973 · Cited by 47 · see citing works

Increased Atherogenic Lipoproteins are Associated With Cognitive Impairment

Carlsson, C. M., Nondahl, D. M., Klein, R., McBride, P. E., Sager, M. A., Schubert, C. R., Klein, R., & Cruickshanks, K. J. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181850188 · Cited by 38 · see citing works

Imaging Biomarkers and their Role in Dementia Clinical Trials

Chertkow, H. M., & Black, S. E. (2007) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s031716710000562x · Cited by 29 · see citing works

Inflammation and Its Relationship to Insulin Resistance, Type 2 Diabetes Mellitus, and Endothelial Dysfunction

Barzilaym, J. I., & Freedland, E. S. (2003) · Metabolic Syndrome and Related Disorders · doi:10.1089/154041903321648252 · Cited by 25 · see citing works

Cholesterol Modulates Vascular Reactivity to Endothelin-1 by Stimulating a Pro-inflammatory Pathway

Paris, D., Town, T., Humphrey, J., Yokota, K., & MULLAN, M. J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3174 · Cited by 21 · see citing works

Commentary on “A roadmap for the prevention of dementia: The inaugural Leon Thal Symposium.” An impending prevention clinical trial for Alzheimer's disease: Roadmaps and realities

Roses, A. D. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.03.007 · Cited by 5 · see citing works

Commentary on “A roadmap for the prevention of dementia: The inaugural Leon Thal Symposium”

Siemers, E., & Paul, S. M. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.03.008 · Cited by 5 · see citing works

The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease

Ferreira, S. T., & Klein, W. L. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.08.003 · Cited by 442 · see citing works

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

Lewczuk, P., Riederer, P. F., O’Bryant, S. E., Verbeek, M. M., Dubois, B., Visser, P. J., Jellinger, K. A., Engelborghs, S., Ramı́rez, A., Parnetti, L., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1375556 · Cited by 308 · see citing works

Blood serum miRNA: Non-invasive biomarkers for Alzheimer's disease

Geekiyanage, H., Jicha, G. A., Nelson, P. T., & Chan, C. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.026 · Cited by 292 · see citing works

High fat diet induces brain insulin resistance and cognitive impairment in mice

Kothari, V. M., Luo, Y., Tornabene, T., O’Neill, A. M., Greene, M. W., Geetha, T., & Babu, J. R. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.10.006 · Cited by 284 · see citing works

APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases

Fernández-Calle, R., Konings, S. C., Frontiñán-Rubio, J., García-Revilla, J., Camprubí-Ferrer, L., Svensson, M., Martinson, I., Boza-Serrano, A., Venero, J. L., Nielsen, H. M., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00566-4 · Cited by 278 · see citing works

Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors

Tayeb, H. O., Yang, H. D., Price, B. H., & Tarazi, F. I. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.12.002 · Cited by 231 · see citing works

Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid‐life: A randomized trial

Hoscheidt, S. M., Sanderlin, A. H., Baker, L. D., Jung, Y., Lockhart, S. N., Kellar, D., Whitlow, C. T., Hanson, A. J., Friedman, S. D., Register, T. C., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12421 · Cited by 170 · see citing works

The Diabetes Drug Liraglutide Ameliorates Aberrant Insulin Receptor Localisation and Signalling in Parallel with Decreasing Both Amyloid-β Plaque and Glial Pathology in a Mouse Model of Alzheimer’s Disease

Long-Smith, C. M., Manning, S., McClean, P. L., Coakley, M. F., O’Halloran, D., Hölscher, C., & O’Neill, C. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8199-5 · Cited by 156 · see citing works

Diabetes and Hypercholesterolemia Increase Blood-Brain Barrier Permeability and Brain Amyloid Deposition: Beneficial Effects of the LpPLA2 Inhibitor Darapladib

Acharya, N. K., Levin, E. C., Clifford, P. M., Han, M. C., Tourtellotte, R., Chamberlain, D., Pollaro, M., Coretti, N. J., Kosciuk, M. C., Nagele, E. P., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122254 · Cited by 140 · see citing works

Cardiovascular risk factors, cortisol, and amyloid‐β deposition in Alzheimer's Disease Neuroimaging Initiative

Toledo, J. B., Toledo, E., Weiner, M. W., Jack, C. R., Jagust, W., Lee, V. M. ‐., Shaw, L. M. J., & Trojanowski, J. Q. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.08.008 · Cited by 130 · see citing works

Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?

Humpel, C. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.11.032 · Cited by 124 · see citing works

Blood–brain barrier-on-a-chip: Microphysiological systems that capture the complexity of the blood–central nervous system interface

Phan, D. T. T., Bender, R. H. F., Andrejecsk, J. W., Sobrino, A., Hachey, S. J., George, S. C., & Hughes, C. C. W. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217694100 · Cited by 119 · see citing works

Bapineuzumab and solanezumab for Alzheimer's disease: is the ‘amyloid cascade hypothesis’ still alive?

Tayeb, H. O., Murray, E. D., Price, B. H., & Tarazi, F. I. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.789856 · Cited by 119 · see citing works

Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets

Fišar, Z. (2022) · Biomolecules · doi:10.3390/biom12111676 · Cited by 110 · see citing works

Vascular and metabolic dysfunction in Alzheimer’s disease: a review

Murray, I. V. J., Proza, J. F., Sohrabji, F., & Lawler, J. M. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.010355 · Cited by 104 · see citing works

Dietary Patterns and Alzheimer’s Disease: An Updated Review Linking Nutrition to Neuroscience

Ellouze, I., Sheffler, J., Nagpal, R., & Arjmandi, B. (2023) · Nutrients · doi:10.3390/nu15143204 · Cited by 104 · see citing works

Evaluating the Association between Diabetes, Cognitive Decline and Dementia

Ojo, O., & Brooke, J. M. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph120708281 · Cited by 96 · see citing works

Chronic epigallocatechin-3-gallate ameliorates learning and memory deficits in diabetic rats via modulation of nitric oxide and oxidative stress

Baluchnejadmojarad, T., & Roghani, M. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.06.007 · Cited by 92 · see citing works

Amyloid-β and Tau Pathology of Alzheimer's Disease Induced by Diabetes in a Rabbit Animal Model

Bitel, C. L., Kasinathan, C., Kaswala, R. H., Klein, W. L., & Frederikse, P. H. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120571 · Cited by 77 · see citing works

Islet amyloid polypeptide: Another key molecule in Alzheimer’s pathogenesis?

Zhang, Y., & Song, W. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.001 · Cited by 78 · see citing works

Nutritional Biomarkers and Subsequent Cognitive Decline Among Community-Dwelling Older Japanese: A Prospective Study

Taniguchi, Y., Shinkai, S., Nishi, M., Murayama, H., Nofuji, Y., Yoshida, H., & Fujiwara, Y. (2014) · The Journals of Gerontology Series A · doi:10.1093/gerona/glt286 · Cited by 71 · see citing works

Biomarkers of Alzheimer's disease and mild cognitive impairment: A current perspective

Lewczuk, P., Mroczko, B., Fagan, A. M., & Kornhuber, J. (2014) · Advances in Medical Sciences · doi:10.1016/j.advms.2014.11.002 · Cited by 70 · see citing works

The role of inflammatory processes in Alzheimer’s disease

Broussard, G. J., Mytar, J. O., Li, R., & Klapstein, G. J. (2012) · Inflammopharmacology · doi:10.1007/s10787-012-0130-z · Cited by 68 · see citing works

Parkinson';s Disease, Diabetes and Cognitive Impairment

Ashraghi, M. R., Pagano, G., Polychronis, S., Niccolini, F., & Politis, M. (2016) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/1872214810999160628105549 · Cited by 68 · see citing works

Mitochondria and NMDA Receptor-Dependent Toxicity of Berberine Sensitizes Neurons to Glutamate and Rotenone Injury

Kysenius, K., Brunello, C. A., & Huttunen, H. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107129 · Cited by 65 · see citing works

Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer’s Disease

Goldwaser, E. L., Acharya, N. K., Sarkar, A., Godsey, G. A., & Nagele, R. G. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160284 · Cited by 65 · see citing works

Insulin Resistance Prevents AMPK-induced Tau Dephosphorylation through Akt-mediated Increase in AMPKSer-485 Phosphorylation

Kim, B., Figueroa‐Romero, C., Pacut, C. M., Backus, C., & Feldman, E. L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.636852 · Cited by 60 · see citing works

Effects of pioglitazone on the incidence of dementia in patients with diabetes

Chou, P., Ho, B., & Yang, Y. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.006 · Cited by 59 · see citing works

Identifying progressive imaging genetic patterns via multi-task sparse canonical correlation analysis: a longitudinal study of the ADNI cohort

Du, L., Liu, K., Zhu, L., Yao, X., Risacher, S., Guo, L., Saykin, A., & Shen, L. (2019) · Bioinform. · doi:10.1093/bioinformatics/btz320 · Cited by 52 · see citing works

High-fat diet increases tau expression in the brain of T2DM and AD mice independently of peripheral metabolic status

Takalo, M., Haapasalo, A., Martiskainen, H., Kurkinen, K. M. A., Koivisto, H., Miettinen, P., Khandelwal, V. K. M., Kemppainen, S., Kamińska, D., Mäkinen, P. M., et al. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.02.003 · Cited by 54 · see citing works

Cerebral Myogenic Reactivity and Blood Flow in Type 2 Diabetic Rats: Role of Peroxynitrite in Hypoxia-Mediated Loss of Myogenic Tone

Kelly-Cobbs, A. I., Prakash, R., Coucha, M. M., Knight, R. A., Li, W., Ogbi, S. N., Johnson, M., & Ergul, A. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.191296 · Cited by 54 · see citing works

Retinal pathology is associated with increased blood–retina barrier permeability in a diabetic and hypercholesterolaemic pig model: Beneficial effects of the LpPLA 2 inhibitor Darapladib

Acharya, N. K., Qi, X., Goldwaser, E. L., Godsey, G. A., Wu, H., Kosciuk, M. C., Freeman, T. A., Macphee, C. H., Wilensky, R. L., Venkataraman, V., et al. (2017) · Diabetes and Vascular Disease Research · doi:10.1177/1479164116683149 · Cited by 51 · see citing works

New Insight into Diabetes Management: From Glycemic Index to Dietary Insulin Index

Yari, Z., Behrouz, V., Zand, H., & Pourvali, K. (2019) · Current Diabetes Reviews · doi:10.2174/1573399815666190614122626 · Cited by 50 · see citing works

A systematic review of type 2 diabetes mellitus and hypertension in imaging studies of cognitive aging: time to establish new norms

Meusel, L.-A., Kansal, N., Tchistiakova, E., Yuen, W., MacIntosh, B. J., Greenwood, C. E., & Anderson, N. D. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00148 · Cited by 46 · see citing works

Chronic Cyanidin‐3‐glucoside Administration Improves Short‐term Spatial Recognition Memory but not Passive Avoidance Learning and Memory in Streptozotocin‐diabetic Rats

Nasri, S., Roghani, M., Baluchnejadmojarad, T., Balvardi, M., & Rabani, T. (2012) · Phytotherapy Research · doi:10.1002/ptr.3702 · Cited by 47 · see citing works

Impact of Insulin Sensitizers on the Incidence of Dementia: A Meta-Analysis

Ye, F., Luo, Y.-J., Xiao, J. F., Yu, N., & Yi, G. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000445941 · Cited by 47 · see citing works

MST1 Regulates Neuronal Cell Death via JNK/Casp3 Signaling Pathway in HFD Mouse Brain and HT22 Cells

Khan, M., Rutten, B. P. F., & Kim, M. O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102504 · Cited by 46 · see citing works

Deep phenotyping of Alzheimer’s disease leveraging electronic medical records identifies sex-specific clinical associations

Tang, A. S., Oskotsky, T., Havaldar, S., Mantyh, W. G., Bicak, M., Solsberg, C. W., Woldemariam, S., Zeng, B., Hu, Z., Oskotsky, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28273-0 · Cited by 45 · see citing works

Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease

Ong, M., Foo, H., Chander, R. J., Wen, M., Au, W. L., Sitoh, Y. Y., Tan, L., & Kandiah, N. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.04.010 · Cited by 45 · see citing works

Autophagy Activation is Associated with Neuroprotection in Diabetes-associated Cognitive Decline

Wu, Y., Ye, L., Yuan, Y., Jiang, T., Guo, X., Wang, Z., Xu, K., Xu, Z., Liu, Y., Zhong, X., et al. (2018) · Aging and Disease · doi:10.14336/ad.2018.1024 · Cited by 41 · see citing works

Receptor-mediated toxicity of human amylin fragment aggregated by short- and long-term incubations with copper ions

Caruso, G., Distefano, D. A., Parlascino, P., Fresta, C. G., Lazzarino, G., Lunte, S. M., & Nicoletti, V. G. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2864-1 · Cited by 39 · see citing works

Navigating the intersection: Diabetes and Alzheimer's intertwined relationship

Kale, M. B., Bhondge, H. M., Wankhede, N. L., Shende, P. V., Thanekar, R., Aglawe, M. M., Rahangdale, S. R., Taksande, B. G., Pandit, S. B., Upaganlawar, A. B., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102415 · Cited by 38 · see citing works

Effects of Plasma Lipids and Statins on Cognitive Function

Li, R., Wang, T., Lyu, P., Liu, Y., Chen, W., Fan, M., & Xu, J. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.225062 · Cited by 37 · see citing works

Neuromodulatory effects of green coffee bean extract against brain damage in male albino rats with experimentally induced diabetes

Albrakati, A., Albarakati, A. J. A., Daabo, H. M. A., Baty, R. S., Salem, F. E. H., Habotta, O. A., Elmahallawy, E. K., Abdel-Mohsen, D. M., Taha, H., Akabawy, A. M. A., et al. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00583-6 · Cited by 37 · see citing works

Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer’s and Parkinson’s Diseases: Insights into Current Medications

Gautam, D., Naik, U. P., Naik, M. U., Yadav, S. K., Chaurasia, R. N., & Dash, D. (2023) · Biomolecules · doi:10.3390/biom13111609 · Cited by 37 · see citing works

The role of thyroid-stimulating hormone in regulating lipid metabolism: Implications for body–brain communication

Wang, X., Zhen, W., Liu, Y., Wu, C., Jiang, J., Hashimoto, K., & Zhou, X. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106658 · Cited by 40 · see citing works

Enhancement of Insulin/PI3K/Akt Signaling Pathway and Modulation of Gut Microbiome by Probiotics Fermentation Technology, a Kefir Grain Product, in Sporadic Alzheimer’s Disease Model in Mice

Sayed, N. S. E., Kandil, E. A., & Ghoneum, M. H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.666502 · Cited by 36 · see citing works

Short-term mechanisms influencing volumetric brain dynamics

Dieleman, N., Koek, H. L., & Hendrikse, J. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.09.002 · Cited by 32 · see citing works

Diabetes mellitus type 2 as an underlying, comorbid or consequent state of mental disorders

Borovčanin, M., Vesić, K., Petrović, I., Jovanović, I., & Mijailović, N. R. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i5.481 · Cited by 30 · see citing works

Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?

Kokjohn, T. A., Maarouf, C. L., & Roher, A. E. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.2429 · Cited by 30 · see citing works

Summative Effects of Vascular Risk Factors on the Progression of Alzheimer Disease

Lee, W., Liao, Y., Wang, Y.-F., Lin, Y., Wang, S., & Fuh, J. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16181 · Cited by 27 · see citing works

Hypothyroidism and Diabetes-Related Dementia: Focused on Neuronal Dysfunction, Insulin Resistance, and Dyslipidemia

Kim, H. K., & Song, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23062982 · Cited by 28 · see citing works

Curcugreen Treatment Prevented Splenomegaly and Other Peripheral Organ Abnormalities in 3xTg and 5xFAD Mouse Models of Alzheimer’s Disease

Manna, J., Dunbar, G. L., & Maiti, P. (2021) · Antioxidants · doi:10.3390/antiox10060899 · Cited by 25 · see citing works

Cognitive dysfunction associated with anti-glutamic acid decarboxylase autoimmunity: a case-control study

Takagi, M., Ishigaki, Y., Uno, K., Sawada, S., Imai, J., Kaneko, K., Hasegawa, Y., Yamada, T., Tokita, A., Iseki, K., et al. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-76 · Cited by 25 · see citing works

Linking senile dementia to type 2 diabetes: role of oxidative stress markers, C-reactive protein and tumor necrosis factor-α

Ragy, M. M., & Kamal, N. N. (2017) · Neurological Research · doi:10.1080/01616412.2017.1312773 · Cited by 25 · see citing works

The Aqueous Extract of Portulaca Oleracea Ameliorates Neurobehavioral Dysfunction and Hyperglycemia Related to Streptozotocin-Diabetes Induced in Ovariectomized Rats.

Tabatabaei, S. R. F., Rashno, M., Ghaderi, S., & Askaripour, M. (2016) · PubMed Central · Cited by 24 · see citing works

Inhibition of aminoacylase 3 protects rat brain cortex neuronal cells from the toxicity of 4-hydroxy-2-nonenal mercapturate and 4-hydroxy-2-nonenal

Tsirulnikov, K., Abuladze, N. K., Bragin, A., Faull, K. F., Cascio, D., Damoiseaux, R. D., Schibler, M. J., & Pushkin, A. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.07.002 · Cited by 22 · see citing works

Cognitive deficits and Alzheimer-like neuropathological impairments during adolescence in a rat model of type 2 diabetes mellitus

Li, W., Jin, L., Li, Y.-P., Feng, Q., Ren, L., Wang, F., & Bo, G.-J. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.239448 · Cited by 22 · see citing works

Pioglitazone improves the ability of learning and memory via activating ERK1/2 signaling pathway in the hippocampus of T2DM rats

Gao, F., Zang, L., Wu, D. Y., Li, Y. J., Zhang, Q., Wang, H. B., Tian, G. L., & Mu, Y. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.04.052 · Cited by 20 · see citing works

You-on-a-chip’ for precision medicine

Low, L. A., & Tagle, D. A. (2018) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2018.1456333 · Cited by 18 · see citing works

Insights into prevention mechanisms of bioactive components from healthy diets against Alzheimer's disease

Wang, J., Yu, Z., Ye, P., & Xu, B. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109397 · Cited by 18 · see citing works

Novel Biomarkers for Alzheimer’s Disease: Plasma Neurofilament Light and Cerebrospinal Fluid

Abukuri, D. N. (2024) · International Journal of Alzheimer s Disease · doi:10.1155/2024/6668159 · Cited by 19 · see citing works

The influence of insulin infusion on the metabolism of amyloid β peptides in plasma

Karczewska‐Kupczewska, M., Lelental, N., Adamska, A., Nikołajuk, A., Kowalska, I., Górska, M., Zimmermann, R., Kornhuber, J., Strączkowski, M., & Lewczuk, P. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.01.013 · Cited by 17 · see citing works

Alzheimer's disease and type 2 diabetes: Two diseases, one common link?

Bartl, J., Monoranu, C., Schilling, A.-K., Kolter, J. F., Riederer, P., & Grünblatt, E. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.650204 · Cited by 17 · see citing works

Current Insights of Nanocarrier-Mediated Gene Therapeutics to Treat Potential Impairment of Amyloid Beta Protein and Tau Protein in Alzheimer’s Disease

Jain, U., Johari, S., & Srivastava, P. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03671-7 · Cited by 16 · see citing works

Protein Modification by Dicarbonyl Molecular Species in Neurodegenerative Diseases

Williams, W. M., Weinberg, A., & Smith, M. A. (2011) · Journal of Amino Acids · doi:10.4061/2011/461216 · Cited by 16 · see citing works

Comparative study of cholinergic and oxidative stress biomarkers in brains of diabetic and hypercholesterolemic rats

Hegazy, A., Abdel-Azeem, A. S., Shahy, E. M., & El-Sayed, E. M. (2015) · Human & Experimental Toxicology · doi:10.1177/0960327115583361 · Cited by 16 · see citing works

Coenzyme Q10 supplementation reverses diabetes-related impairments in long-term potentiation induction in hippocampal dentate gyrus granular cells: An in vivo study

Omidi, G., Karimi, S. A., Shahidi, ‬., Faraji, N., & Komaki‬, A. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146475 · Cited by 15 · see citing works

Saffron as a promising therapy for diabetes and Alzheimer's disease: mechanistic insights

Sanaie, S., Nikanfar, S., Yousefi, Z., Azizi-Zeinalhajlou, A., Sadigh‐Eteghad, S., Araj‐Khodaei, M., Ayati, M. H., & Andalib, S. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01059-5 · Cited by 15 · see citing works

Improving effect of Actinidia arguta leaf on hyperglycemia-induced cognitive dysfunction

Yoo, S. K., Kang, J. Y., Lee, U., Park, S. K., Kim, J. M., Han, H. J., Kim, D., & Heo, H. J. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104315 · Cited by 13 · see citing works

The Interaction Between Vascular Risk Factors, Cerebral Small Vessel Disease, and Amyloid Burden in Older Adults

Koncz, R., Initiative, A. D. N., Wen, W., Makkar, S. R., Lam, B. C. P., Crawford, J. D., Rowe, C. C., & Sachdev, P. S. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-210358 · Cited by 12 · see citing works

Neuroimaging correlates of Alzheimer's disease biomarker concentrations in a racially diverse high‐risk cohort of middle‐aged adults

Misiura, M. B., Munkombwe, C., Igwe, K. C., Verble, D. D., Likos, K. D. S., Minto, L. R., Bartlett, A., Zetterberg, H., Turner, J. A., Dotson, V. M., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14051 · Cited by 9 · see citing works

Mechanistic Approach to Immunity and Immunotherapy of Alzheimer’s Disease: A Review

Islam, M. R., Rabbi, M. A., Hossain, T., Sultana, S., & Uddin, S. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00360 · Cited by 10 · see citing works

Genetic polymorphisms of lipid metabolism gene SAR1 homolog B and the risk of Alzheimer's disease and vascular dementia

Chen, J., Hsieh, C.-J., Huang, Y., Chen, Y., Chen, T., Sun, Y., Wen, L., Yip, P., & Chu, Y. (2015) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2015.01.008 · Cited by 10 · see citing works

Clinical characteristics of cognitive impairment and its related risk factors in post‐stroke epilepsy

Hou, H., Sun, G., Duan, Z., Tao, L., Zhang, S., & Fang, Q. (2022) · Epileptic Disorders · doi:10.1684/epd.2022.1442 · Cited by 9 · see citing works

Risk of Dementia in Diabetic Patients with Hyperglycemic Crisis: A Nationwide Taiwanese Population-Based Cohort Study

Chou, C., Feng, I., Chen, Y., Chen, J., Lin, H., Wang, J., Hsu, C., & Huang, C. (2020) · Neuroepidemiology · doi:10.1159/000509754 · Cited by 9 · see citing works

Cerebrovascular and Blood-Brain Barrier Compromise: A Mechanistic Link between Vascular Disease and Alzheimer’s Disease Subtypes of Neurocognitive Disorders

Goldwaser, E. L., Acharya, N. K., & Nagele, R. G. (2015) · Journal of Parkinson’s Disease and Alzheimer’s Disease · doi:10.13188/2376-922x.1000013 · Cited by 8 · see citing works

Optimizing clinical phenotyping to better delineate the complex relationship between type 2 diabetes and Alzheimer’s disease

Hanson, A. J., & Rubinow, K. B. (2021) · Clinical and Translational Science · doi:10.1111/cts.13024 · Cited by 8 · see citing works

Lipidomics and cognitive dysfunction – A Narrative review

Chakraborty, A., Praharaj, S. K., Prabhu, R. V. K., & Prabhu, M. M. (2020) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2020-0134 · Cited by 8 · see citing works

The relationship between urinary Alzheimer-associated neuronal thread protein and blood biochemical indicators in the general population

Li, Y., Guan, S., He, J., Liu, H., Kang, M., Wang, X., Sheng, C., Sun, Y., Li, X., Fang, X., et al. (2020) · Aging · doi:10.18632/aging.103356 · Cited by 8 · see citing works

Alzheimer’s Disease: Current and Future Treatments. A Review

Chou, E. (2014) · International Journal of Medical Students · doi:10.5195/ijms.2014.85 · Cited by 8 · see citing works

Effects of Artemisia macrocephala Jacquem on Memory Deficits and Brain Oxidative Stress in Streptozotocin-Induced Diabetic Mice

Bari, A. U., Shah, S. M. M., Al-Joufi, F. A., Shah, S. W. A., Shoaib, M., Shah, I., Zahoor, M., Ahmed, M. N., Ghias, M., Shah, S. M. H., et al. (2022) · Molecules · doi:10.3390/molecules27082399 · Cited by 7 · see citing works

THE EFFECT OF SEMBUNG LEAF EXTRACT (BLUMEA BALSAMIFERA) ON THE NUMBER AND DIAMETER OF RATS LEYDIG CELLS INDUCED BY HIGH-FAT DIET

Widhiantara, G., Permatasari, A. A. A. P., & Wiradana, P. A. (2021) · PLANT ARCHIVES · doi:10.51470/plantarchives.2021.v21.no1.049 · Cited by 6 · see citing works

Lipoprotein binding to anionic biopolyelectrolytes and the effect of glucose on nanoplaque formation in arteriosclerosis and Alzheimer's disease

Siegel, G., Mockenhaupt, F. P., Behnke, A., Ermilov, E. A., Winkler, K. E., Pries, A. R., Malmsten, M., Hetzer, R., Saunders, R., & Lindman, B. (2016) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2016.02.001 · Cited by 6 · see citing works

Methylation factor MRPL15 identified as a potential biological target in Alzheimer’s disease

Gao, L., Li, J., Yan, M., & Aili, M. (2021) · Aging · doi:10.18632/aging.202862 · Cited by 6 · see citing works

EFFECT OF METFORMIN AND SIMVASTATIN IN DIAZEPAM-AND SODIUM NITRITE-INDUCED ANTEROGRADE AMNESIA IN MALE SWISS ALBINO MICE

Ss, T., & Sugato, C. H. (2018) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2018v10i6.19113 · Cited by 5 · see citing works

Vascular Risk Factors and Cognition in Multiple System Atrophy

Zhang, L., Hou, Y., Cao, B., Wei, Q., Ou, R., Liu, K., Lin, J., Yang, T., Xiao, Y., Zhao, B., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.749949 · Cited by 5 · see citing works

Metabolic Syndrome and Dementia

Lee, A. Y. (2011) · Journal of the Korean Neurological Association · Cited by 6 · see citing works

Memory-Enhancing Effects of Daidzin, Possibly Through Dopaminergic and AChEergic Dependent Pathways

Islam, M. T., Prottay, A. A. S., Bhuia, M. S., Akbor, M. S., Chowdhury, R., Ansari, S. A., Ansari, I. A., Islam, M. A., Tahim, C. M., & Coutinho, H. D. M. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.04.024 · Cited by 4 · see citing works

The Effect of Cognitive Training in a Day Care Center in Patients with Early Alzheimer’s Disease Dementia: A Retrospective Study

Kwon, H. S., Yang, H.-R., Yun, K., Baek, J. S., Kim, Y. U., Park, S.-H., & Choi, H. (2020) · Psychiatry Investigation · doi:10.30773/pi.2020.0170 · Cited by 5 · see citing works

Stearoyl-CoA desaturases sustain cholinergic excitation and copulatory robustness in metabolically aging C. elegansmales

Goncalves, J. F., Yu, W. C., & Garcia, L. R. (2021) · iScience · doi:10.1016/j.isci.2022.104082 · Cited by 4 · see citing works

Currently Available Biomarkers and Strategies for the Validation of Novel Candidates for Neurochemical Dementia Diagnostics in Alzheimer’s Disease and Mild Cognitive Impairment

Lewczuk, P. (2014) · Advances in Geriatrics · doi:10.1155/2014/891780 · Cited by 4 · see citing works

Cognitive screening in patients with diabetes in primary care

Brooke, J. M., & Ojo, O. (2014) · British Journal of Community Nursing · doi:10.12968/bjcn.2014.19.8.401 · Cited by 3 · see citing works

16. The relationship between cholesterol metabolism and inflammation in chronic disease

Andersen, C. J., Doerr, A., Murphy, K. E., & McNeely, T. L. (2016) · Wageningen Academic Publishers eBooks · doi:10.3920/978-90-8686-821-6_16 · Cited by 3 · see citing works

APOE gene region methylation is associated with cognitive performance in middle-aged urban adults

Shen, B., Hernandez, D. G., Chitrala, K. N., Kuczmarski, M. F., Hooten, N. N., Pacheco, N. L., Mode, N. A., Zonderman, A. B., Ezike, N., & Evans, M. K. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.03.010 · Cited by 3 · see citing works

China should emphasize understanding and standardized management in diabetic cognitive dysfunction

Yin, Q., Yan, G., Wang, X., Li, S., Hou, X., & Bi, W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1195962 · Cited by 3 · see citing works

Role of Hypertension and Hyperlipidemia in the Pathogenesis of Dementia

Kaira, M., Walia, V., & Garg, M. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_10 · Cited by 3 · see citing works

β -1,3-Glucans-rich Euglena gracilis supplementation alleviates high-fat-high-fructose diet-induced cognitive impairment in middle-aged mice via the gut-brain axis

Xu, H., Wang, Y., Li, X., Wu, X., Lu, L. W., He, J., Wang, M., Liu, B., Xu, H., Chen, J., et al. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250284 · Cited by 2 · see citing works

From Herbal Tea to Science: Phytochemical and Biological Investigation of Ajuga chamaepitys subsp. chia (Lamiaceae) With Molecular Docking Analysis

Aydın, B., Aydın, A. S., Çeçen, Ö., Yuca, H., Bona, G. E., Demırcı, B., Bona, M., & Karakaya, S. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70749 · Cited by 2 · see citing works

Genomic Linkage Between Alzheimer's Disease and Type 2 Diabetes

Nedjadi, T., Haque, A., Alam, Q., Gan, S. H., Chaudhary, A., Abuzenadah, A. M., Damanhouri, G. A., & Kamal, M. A. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660140 · Cited by 2 · see citing works

Adiposity, Type 2 Diabetes, and Alzheimer's Disease

Luchsinger, J. A., & Gustafson, D. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1022 · Cited by 212 · see citing works

Therapy insight, type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease

Haan, M. N. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0124 · Cited by 284 · see citing works

Type 2 diabetes, related conditions, in relation and dementia: An opportunity for prevention?

Luchsinger, J. A. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091687 · Cited by 91 · see citing works

Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease

Cummings, J. L., Ortiz, A. A., Castellino, J., & Kinney, J. W. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15619 · Cited by 50 · see citing works

Diabetes, related conditions, and dementia

Luchsinger, J. A. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.063 · Cited by 86 · see citing works